V. Kulkarni

发表

Molecular modeling of protein tyrosine phosphatase 1B (PTP 1B) inhibitors.

V. S. Murthy, V. Kulkarni, Vithal M Kulkarni, 2002, Bioorganic & medicinal chemistry.

A molecular dynamics study of the three‐dimensional model of human synovial fluid phospholipase A2—transition state mimic complexes

V. Kulkarni, V. Hariprasad, 1996 .

Pharmacophore generation and atom-based 3D-QSAR of novel 2-(4-methylsulfonylphenyl)pyrimidines as COX-2 inhibitors

V. Kulkarni, Ujashkumar A. Shah, Hemantkumar S. Deokar, 2010, Molecular Diversity.

3D-QSAR of histone deacetylase inhibitors: hydroxamate analogues.

V. Kulkarni, Hemantkumar S. Deokar, D. Juvale, 2006, Organic & biomolecular chemistry.

Three-dimensional quantitative structure-activity relationship (3D-QSAR) of 3-aryloxazolidin-2-one antibacterials.

V. Kulkarni, R G Karki, V M Kulkarni, 2001, Bioorganic & medicinal chemistry.

3D-QSAR of Cyclooxygenase-2 Inhibitors by Genetic Function Approximation #

V. Kulkarni, BioChem Press, A. Raichurkar, 2003 .

QSAR OF BACTERIAL FOLATE-SYNTHESIS INHIBITORS

V. Kulkarni, J. Seydel, E. Coats, 1983 .

Understanding the antifungal activity of terbinafine analogues using quantitative structure-activity relationship (QSAR) models.

V. Kulkarni, V. Gokhale, 2000, Bioorganic & medicinal chemistry.

Effect of a novel biphenyl compound, VMNS2e on ob/ob mice.

V. Kulkarni, V. Ghole, S. Bodhankar, 2011, European journal of pharmacology.

QSAR of HIV-1 integrase inhibitors by genetic function approximation method.

Mahindra T. Makhija, V. Kulkarni, 2002, Bioorganic & medicinal chemistry.

Novel curcumin analogs targeting TNF-induced NF-kappaB activation and proliferation in human leukemic KBM-5 cells.

B. Aggarwal, V. Kulkarni, S. Padhye, 2006, Bioorganic & medicinal chemistry.

Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma.

V. Kulkarni, Siddharth J Modi, 2020, European journal of medicinal chemistry.

Correlation between electronic indices from molecular orbital calculations and antiradiation activity of thiazolidines.

V. Kulkarni, H. P. Tipnis, 1976, Experientia. Supplementum.

Inhibitory activity and mode of action of diaminodiphenylsulfone in cell-free folate-synthesizing systems prepared from Mycobacterium lufu and Mycobacterium leprae. A comparison.

V. Kulkarni, J. Seydel, 1983, Chemotherapy.

Human protein tyrosine phosphatase 1B inhibitors: QSAR by genetic function approximation

V. Kulkarni, S. Kadam, N. Sachan, 2007, Journal of enzyme inhibition and medicinal chemistry.

Exploration of structural requirements for the inhibition of VEGFR-2 tyrosine kinase: Binding site analysis of type II, ‘DFG-out’ inhibitors

V. Kulkarni, Siddharth J Modi, 2021, Journal of biomolecular structure & dynamics.

Copper Conjugates of Knoevenagel Condensates of Curcumin and their Schiff Base Derivatives: Synthesis, Spectroscopy, Magnetism, ESR, and Electrochemistry

V. Kulkarni, S. Padhye, A. Jamadar, 2007 .

Three-dimensional quantitative structure-activity relationship of 1,4-dihydropyridines as antitubercular agents.

V. Kulkarni, Anamik Shah, P. Kharkar, 2002, Journal of medicinal chemistry.

Synthesis and antifungal activity of some azetidinones.

Vilasrao J. Kadam, V. M. Kulkarni, V. Kulkarni, 2009 .

Vascular Endothelial Growth Factor Receptor (VEGFR-2)/KDR Inhibitors: Medicinal Chemistry Perspective

V. Kulkarni, Siddharth J Modi, 2019, Medicine in Drug Discovery.

QSAR and Molecular Docking of Phthalazine Derivatives as Epidermal Growth Factor Receptor (EGFR) Inhibitors

V. Kulkarni, Siddharth J Modi, M. G. Shinde, 2017 .

Azetidinone : A bioactive moiety

V. Kulkarni, V. Kadam, N. Mumbai, 2010 .

Multiple Regression and Principal Component Analysis of Antibacterial Activities of Sulfones and Sulfonamides in Whole Cell and Cell-Free Systems of Various DDS Sensitive and Resistant Bacterial Strains

V. Kulkarni, M. Wiese, K. Schaper, 1985 .

Insights into the selective inhibition of Candida albicans secreted aspartyl protease: a docking analysis study.

V. Kulkarni, S. K. Pranav Kumar, 2002, Bioorganic & medicinal chemistry.

Design, synthesis, antifungal activity, and ADME prediction of functional analogues of terbinafine

Vithal M. Kulkarni, Prashant S. Kharkar, V. Kulkarni, 2009, Medicinal Chemistry Research.

Synthesis, Pharmacological Evaluation, Molecular Docking and in silico ADMET Prediction of Nitric Oxide Releasing Biphenyls as Anti-Inflammatory Agents

V. Kulkarni, Siddharth J Modi, M. G. Shinde, 2017 .

Structure Based Prediction of Binding Affinity of Human Immunodeficiency Virus-1 Protease Inhibitors

Vithal M. Kulkarni, Santosh S. Kulkarni, V. Kulkarni, 1999, J. Chem. Inf. Comput. Sci..

Three-dimensional quantitative structure-activity relationship (QSAR) and receptor mapping of cytochrome P-450(14 alpha DM) inhibiting azole antifungal agents.

V. Kulkarni, T. Talele, T T Talele, 1999, Journal of chemical information and computer sciences.

Docking analysis of a series of cytochrome P-450(14) alpha DM inhibiting azole antifungals.

V. Kulkarni, V. Hariprasad, T. Talele, 1998, Drug design and discovery.

Microwave assisted synthesis of potential anti infective and anticonvulsant thiosemicarbazones.

V. Kulkarni, V. Kadam, M. P. Toraskar, 2009 .

ANTI-INFLAMMATORY AND ANALGESIC ACTIVITY OF 4'-METHYLBIPHENYL-2- (SUBSTITUTED PHENYL) CARBOXAMIDE ANALOGS IN ANIMAL MODELS OF INFLAMMATION

V. Kulkarni, Hemantkumar S. Deokar, N. Wagh, 2006 .

Comparative molecular field analysis of fungal squalene epoxidase inhibitors.

V. Kulkarni, V. Gokhale, 1999, Journal of medicinal chemistry.

Conformational structure of propranolol: A β‐adrenergic blocking drug studied by NMR and PCILO methods

V. Kulkarni, G. Govil, A. Saran, 2009 .

De novo design and synthesis of HIV-1 integrase inhibitors.

Mahindra T. Makhija, Nouri Neamati, N. Neamati, 2004, Bioorganic & medicinal chemistry.

Combined 2D and 3D-QSAR, molecular modelling and docking studies of pyrazolodiazepinones as novel phosphodiesterase 2 inhibitors

V. Kulkarni, S. Bhansali, 2014, SAR and QSAR in environmental research.

Selectivity analysis of 5-(arylthio)-2,4-diaminoquinazolines as inhibitors of Candida albicans dihydrofolate reductase by molecular dynamics simulations

Vithal M. Kulkarni, Vijay M. Gokhale, V. Kulkarni, 2000, J. Comput. Aided Mol. Des..

Conformational studies of antiradiation agents by NMR: cysteamine and its derivatives.

V. Kulkarni, G. Govil, 1977, Journal of pharmaceutical sciences.

Reversal of TGF-β-induced epithelial–mesenchymal transition in hepatocellular carcinoma by sorafenib, a VEGFR-2 and Raf kinase inhibitor

V. Kulkarni, Siddharth J Modi, Anshuly Tiwari, 2021, Current research in pharmacology and drug discovery.

Pharmacophore generation, atom-based 3D-QSAR, docking, and virtual screening studies of p38-α mitogen activated protein kinase inhibitors: pyridopyridazin-6-ones (part 2)

V. Kulkarni, Sujit G. Bhansali, 2013 .

Evaluation of piperine against cancer stem cells (CSCs) of hepatocellular carcinoma: Insights into epithelial-mesenchymal transition (EMT).

V. Kulkarni, Siddharth J Modi, S. Gabhe, 2021, Bioorganic chemistry.

A proposed common spatial pharmacophore and the corresponding active conformations of some peptide leukotriene receptor antagonists

Vithal M. Kulkarni, V. Hariprasad, V. Kulkarni, 1996, J. Comput. Aided Mol. Des..

Three-dimensional quantitative structure activity relationships (3-D-QSAR) of antihyperglycemic agents.

L. Gediya, V. Kulkarni, S. Kulkarni, 1999, Bioorganic & medicinal chemistry.

A proposed model of Mycobacterium avium complex dihydrofolate reductase and its utility for drug design.

V. Kulkarni, P. Kharkar, 2003, Organic & biomolecular chemistry.

Synthesis, QSAR and hypoglycemic activity of substituted 2, 4- thiazolidinediones

V. Kulkarni, R. S. Bahare, 2011 .

3D-QSAR of N-myristoyltransferase inhibiting antifungal agents by CoMFA and CoMSIA methods.

P. Purushottamachar, V. Kulkarni, Vithal M Kulkarni, 2003, Bioorganic & medicinal chemistry.

A feature based pharmacophore for Candida albicans MyristoylCoA: protein N-myristoyltransferase inhibitors.

V. Kulkarni, R G Karki, V M Kulkarni, 2001, European journal of medicinal chemistry.

3D-QSAR of p38-α mitogen-activated protein kinase inhibitors: pyridopyridazin-6-ones (part 1)

V. Kulkarni, Sujit G. Bhansali, 2013 .

Quinazoline Derivatives as Anticancer Agents: QSAR, Molecular Docking and in silico Pharmacokinetic Prediction

V. Kulkarni, Siddharth J Modi, 2018, Indian Journal of Pharmaceutical Education and Research.

PHARMACOPHORE MODELING AND ATOM-BASED 3D-QSAR STUDIES OF ANTIFUNGAL BENZOFURANS

V. Kulkarni, K. Mahadik, Sujit G. Bhansali, 2015 .

QSAR analysis of N-myristoyltransferase inhibitors: antifungal activity of benzofurans

V. Kulkarni, Hemantkumar S. Deokar, P. Puranik, 2009, Medicinal Chemistry Research.

Novel biphenyl compound, VMNS2e, ameliorates streptozotocin‐induced diabetic nephropathy in rats

V. Kulkarni, S. D'souza, G. Vanage, 2010, Journal of diabetes.

3D-QSAR analysis of pyrimidine derivatives as AXL kinase inhibitors as anticancer agents

V. Kulkarni, Siddharth J Modi, 2018, Journal of Applied Pharmaceutical Science.

Evaluation of Anti-inflammatory and Analgesic Activity of a New Class of Biphenyl Analogs in Animal Models of Inflammation

V. Kulkarni, N. Wagh, S. Bodhankar, 2006, Arzneimittelforschung.

3d-QSAR Of Biphenyl Analogues As Anti-Inflammatory Agents By Genetic Function Approximation (GFA) (Part-II)

V. Kulkarni, Ujashkumar A. Shah, Hemantkumar S. Deokar, 2010 .

Design, Synthesis, Pharmacological Screening And Molecular Docking Of Biphenyl Analogues As Anti-Inflammatory Agents (Part-I)

V. Kulkarni, Ujashkumar A. Shah, Hemantkumar S. Deokar, 2010 .

Isothiocyanate: cancer chemopreventive agent.

V. Kulkarni, V. Kadam, M. P. Toraskar, 2009 .

Fibroblast growth factor receptor (FGFR) inhibitors as anticancer agents: 3D-QSAR, molecular docking and dynamics simulation studies of 1, 6-naphthyridines and pyridopyrimidines

V. Kulkarni, Hemantkumar S. Deokar, Siddharth J Modi, 2022, Journal of biomolecular structure & dynamics.

An in-silico approach: identification of PPAR-γ agonists from seaweeds for the management of Alzheimer’s Disease

V. Kulkarni, Satvik Kotha, S. B., 2020, Journal of biomolecular structure & dynamics.

Design, synthesis, and computational studies of phenylacetamides as antidepressant agents

V. Kulkarni, A. Kanhed, S. Bhosale, 2022, Molecular Diversity.

Understanding the antitumor activity of novel hydroxysemicarbazide derivatives as ribonucleotide reductase inhibitors using CoMFA and CoMSIA.

V. Kulkarni, A. Raichurkar, 2003, Journal of medicinal chemistry.

Eigen Value Analysis of HIV-1 Integrase Inhibitors

Mahindra T. Makhija, Vithal M. Kulkarni, V. Kulkarni, 2001, J. Chem. Inf. Comput. Sci..

Three-dimensional quantitative structure-activity relationship of interleukin 1-beta converting enzyme inhibitors: A comparative molecular field analysis study.

V. Kulkarni, S. Kulkarni, V M Kulkarni, 1999, Journal of medicinal chemistry.

A molecular dynamics study of the three‐dimensional model of human synovial fluid phospholipase A2—transition state mimic complexes

V. Kulkarni, V. Hariprasad, 1996, Journal of molecular recognition : JMR.

3D-QSAR and molecular modeling of HIV-1 integrase inhibitors

Mahindra T. Makhija, Vithal M. Kulkarni, V. Kulkarni, 2002, J. Comput. Aided Mol. Des..

Molecular electrostatic potentials as input for the alignment of HIV-1 integrase inhibitors in 3D QSAR

Mahindra T. Makhija, Vithal M. Kulkarni, V. Kulkarni, 2001, J. Comput. Aided Mol. Des..